Floatz logo

Modified Vaccinia Virus Ankara Vaccine Expressing P53

Stage IV Colon Cancer

City of Hope Medical CentervaccinePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

47 Active assets in the Stage IV Colon Cancer cohort.

Asset / SponsorPhaseRating
Eloxatin
Sun Yat-sen University
Phase 3BBB
FLUOROURACILUM
Merck Sharp & Dohme LLC
Phase 3BBB
Irinotecan
Sun Yat-sen University
Phase 3BBB
Irinotecan
SWOG Cancer Research Network
Phase 3BBB
Eloxatin
Merck Sharp & Dohme LLC
Phase 3BBB

View all 50 →

Same molecule, other indications

Modified Vaccinia Virus Ankara Vaccine Expressing P53 is also rated in:

ovarian carcinomaDormant
B
Indicative ·
60 / 100
View asset →
primary peritoneal carcinomaDormant
B
Indicative ·
60 / 100
View asset →
fallopian tube carcinomaDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →